A model for evaluating the institutional costs and benefits of ICT initiatives in teaching and learning in higher education par David Nicol, Michael Coen

Accéder au texte intégral

The importance of cost-benefit analysis: a response par David Nicol, Michael Coen

Accéder au texte intégral

EDITORIAL. TECHNOLOGIES AS ASSESSMENT CHANGE AGENTS par Valentina Grion, Anna Serbati, David Nicol

Accéder au texte intégral

EDITORIAL. TECHNOLOGY AS A SUPPORT TO TRADITIONAL ASSESSMENT PRACTICES par Valentina Grion, Anna Serbati, David Nicol

Accéder au texte intégral

Understanding the health-related quality of life and treatment-related side-effects in patients who have been in remission from testicular cancer for 12–24 months par Walter Cazzaniga, Janette Kinsella, Adam Kieran Pearce, Masood Moghul, Louis Fox, Mieke Van Hemelrijck, Alison Reid, Alison Reid, Robert Huddart, Robert Huddart, David Nicol, David Nicol

Accéder au texte intégral

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and Nort... par Declan Cahill, Mieke Van Hemelrijck, Masood Moghul, Charlotte Louise Moss, Jai Seth, Vincent Khoo, Nicholas D James, Emma Yates, John Withington, Kathie Wong, Netty Kinsella, David Nicol, Ramanathan Kasivisvanathan, Kyriaki Giorgakoudi, Chris Cottrell

Accéder au texte intégral

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma par Xiaona Wei, Yukti Choudhury, Weng Khong Lim, John Anema, Richard J. Kahnoski, Brian Lane, John Ludlow, Masayuki Takahashi, Hiro-omi Kanayama, Arie Belldegrun, Hyung L. Kim, Craig Rogers, David Nicol, Bin Tean Teh, Min-Han Tan

Accéder au texte intégral

COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility par Heike Goebel, Barbara Koeditz, Manuel Huerta, Ersen Kameri, Tim Nestler, Thomas Kamphausen, Johannes Friemann, Matthias Hamdorf, Timo Ohrmann, Philipp Koehler, Oliver A. Cornely, Manuel Montesinos-Rongen, David Nicol, Hubert Schorle, Peter Boor, Alexander Quaas, Christian Pallasch, Axel Heidenreich, Melanie von Brandenstein

Accéder au texte intégral

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. par Niedzica Camacho, Peter Van Loo, Sandra Edwards, Jonathan D Kay, Lucy Matthews, Kerstin Haase, Jeremy Clark, Nening Dennis, Sarah Thomas, Barbara Kremeyer, Jorge Zamora, Adam P Butler, Gunes Gundem, Sue Merson, Hayley Luxton, Steve Hawkins, Mohammed Ghori, Luke Marsden, Adam Lambert, Katalin Karaszi, Gill Pelvender, Charlie E Massie, Zsofia Kote-Jarai, Keiran Raine, David Jones, William J Howat, Steven Hazell, Naomi Livni, Cyril Fisher, Christopher Ogden, Pardeep Kumar, Alan Thompson, David Nicol, Erik Mayer, Tim Dudderidge, Yongwei Yu, Hongwei Zhang, Nimish C Shah, Vincent J Gnanapragasam, CRUK-ICGC Prostate Group, William Isaacs, Tapio Visakorpi, Freddie Hamdy, Dan Berney, Clare Verrill, Anne Y Warren, David C Wedge, Andrew G Lynch, Christopher S Foster, Yong Jie Lu, G Steven Bova, Hayley C Whitaker, Ultan McDermott, David E Neal, Rosalind Eeles, Rosalind Eeles, Colin S Cooper, Daniel S Brewer

Accéder au texte intégral